MedPath

Clinical Study on Qingming Decoction in Treating Gout of Qi Deficiency and Dampness Accumulation Syndrome

Phase 1
Recruiting
Conditions
Gout
Registration Number
ITMCTR2100005377
Lead Sponsor
Yunnan Hospital of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) Patients with gout diagnosis;(2) Patients with gout intermittency diagnostic criteria: past history of gout, and is not in acute onset of gout, blood uric acid value: male=420µmol/L(7mg/dl), female=360µmol/L(6mg/dl); (3) Those who meet the TCM diagnostic criteria of gout qi deficiency and dampness accumulation syndrome; (4) Those aged between 18 and 65 years old; (5) Patients who did not have acute gout attack 2 weeks before joining the group, did not take non-buxostat and other uric acid-lowering drugs within 2 weeks, and did not take hormone drugs within 1 month; (6) Patients who did not participate in other clinical drug trials and voluntarily participated in this trial signed informed consent.

Exclusion Criteria

(1) Those who do not meet the above inclusion criteria; (2) Patients with acute gouty arthritis at screening; (3) Secondary gout, such as secondary to kidney disease, blood diseases; (4) Patients with diseases that affect basic survival, such as AIDS and malignant tumors; (5) pregnant women, lactating women or women who may be pregnant; (6) Blood ALT, AST, Cr beyond the normal value of 1.5 times or more; (7) patients with allergic constitution and allergic to the drugs used in this study; (8) persons with alcohol, drug or substance abuse; (9) Patients who were receiving treatment with thiopurine and mercaptopurine.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
BMI;Routine Urine Test;Renal Function;blood lipids;Blood Routine Examination;Stool OB;Stool Routine Examination;Liver Function;TCM syndrome scoring;the SF-36 scale;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath